Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2092]
News [6483]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Linking Lynch Syndrome and microsatellite instability in tumours
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
Linking Lynch Syndrome and microsatellite instability in tumours ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
Diagnosis and management of smouldering myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Diagnosis and management of smouldering myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
2 May 2018
The evolution of imaging techniques for multiple myeloma
Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy
The evolution of imaging techniques for multiple myeloma ( Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy )
2 May 2018
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer
Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Neoadjuvant nivolumab for resectable lung cancer
Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018
Biomarkers of pembrolizumab response in head and neck cancer
Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA
Biomarkers of pembrolizumab response in head and neck cancer ( Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA )
25 Apr 2018
Phase I taselisib results and a cell-free DNA assay
Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Phase I taselisib results and a cell-free DNA assay ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018
Safety indications in mouse models treated with full doses of MEK inhibitors...
Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York...
Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099 ( Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical, New York, USA )
25 Apr 2018
A variety of approaches to measure the efficacy of PARP inhibitors
Dr Elisabetta Leo - AstraZeneca, Cambridge, UK
A variety of approaches to measure the efficacy of PARP inhibitors ( Dr Elisabetta Leo - AstraZeneca, Cambridge, UK )
25 Apr 2018
Development and clinical indications of PARP inhibitors
Dr Mark O'Connor - AstraZeneca, Cambridge, UK
Development and clinical indications of PARP inhibitors ( Dr Mark O'Connor - AstraZeneca, Cambridge, UK )
25 Apr 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation